Subscribe To
LMAT / LeMaitre Vascular, Inc. (LMAT) Q4 2022 Earnings Call Transcript
LMAT News
By GlobeNewsWire
November 3, 2023
LeMaitre to Participate at Upcoming Investor Conferences in November
BURLINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in th more_horizontal
By Seeking Alpha
November 1, 2023
LeMaitre Vascular, Inc. (LMAT) Q3 2023 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q3 2023 Earnings Conference Call November 1, 2023 5:00 PM ET Company Participants Joseph Pellegrino - Chief Fin more_horizontal
By Zacks Investment Research
October 23, 2023
PETQ or LMAT: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Products sector might want to consider either PetIQ (PETQ) or LeMaitre Vascular (LMAT). But which of the more_horizontal
By GlobeNewsWire
September 21, 2023
LeMaitre to Present at the 2023 Cantor Global Healthcare Conference
BURLINGTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will presen more_horizontal
By The Motley Fool
September 1, 2023
Looking for Dividend Growth? Buy This Little-Known Healthcare Stock
LeMaitre Vascular's sales and profits surged in the second quarter. The company's dividend is supported by earnings. more_horizontal
By Seeking Alpha
August 24, 2023
LeMaitre: Record Quarter, ASPs And Volumes Ratcheting Higher Equals Qualified Growth Outlook
LeMaitre Vascular's stock offers attractive long-term investment prospects, with recent consolidations offering an entry point for investors. The comp more_horizontal
By Seeking Alpha
August 1, 2023
LeMaitre Vascular, Inc. (LMAT) Q2 2023 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Joseph Pellegrino - Chief Finan more_horizontal
By Zacks Investment Research
August 1, 2023
LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Beat Estimates
LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares t more_horizontal